Ono cans 2 endocannabinoid drug studies after quintuple Phase 2 failure
Ono Pharma’s endocannabinoid modulator showed no effect in easing depression and social anxiety disorder during a group of Phase 2…
Ono Pharma’s endocannabinoid modulator showed no effect in easing depression and social anxiety disorder during a group of Phase 2…